Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03287635 · ClinicalTrials.gov registry record · Phase 4
Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
A Phase 4 study, sponsored by Toyos Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT03287635 is a Phase 4 study that has completed, run by Toyos Clinic. The registered enrollment target is 19 participants.
The verdict
NCT03287635, a Phase 4 study, has completed, sponsored by Toyos Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects with Dry Eye Disease
Interventions
- DRUG Corticotropin 80Unit/Ml Repository Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-03-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03287635
The ClinicalTrials.gov registry entry for NCT03287635 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Toyos Clinic, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corticotropin 80Unit/Ml Repository Injection is the first listed.
NCT03287635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03287635 about?
NCT03287635 is a clinical study titled "Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease". Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects with Dry Eye Disease
What is the current status of trial NCT03287635?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2018-07-01. Estimated completion is 2020-03-04.
What interventions are being tested in trial NCT03287635?
The interventions under investigation include: Corticotropin 80Unit/Ml Repository Injection (DRUG).
Who is sponsoring clinical trial NCT03287635?
This trial is sponsored by Toyos Clinic, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.